chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: light sensitivity; didn't feel great; flu like symptoms; she turned hot then cold then hot again; arm started "itching beyond itching"; injection site became a lump the size of her hand; headaches; fatigued; arm was warm; arm was red; Arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was warm), PHOTOPHOBIA (light sensitivity), MALAISE (didn't feel great), INFLUENZA LIKE ILLNESS (flu like symptoms) and BODY TEMPERATURE FLUCTUATION (she turned hot then cold then hot again) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0301-20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy, Immune thrombocytopenic purpura, Asthma, Diabetes and Psoriatic arthritis. Concomitant products included METOPROLOL TARTRATE (METOPROLOL - 1 A PHARMA), QUINAPRIL, METFORMIN HCL, PIOGLITAZONE, HYDROCHLOROTHIAZIDE, GLIPIZIDE, CANAGLIFLOZIN, ATORVASTATIN, EXENATIDE and SECUKINUMAB (COSENTYX) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE WARMTH (arm was warm), VACCINATION SITE SWELLING (Arm swollen) and VACCINATION SITE ERYTHEMA (arm was red). On 23-Feb-2021, the patient experienced PHOTOPHOBIA (light sensitivity), MALAISE (didn't feel great), INFLUENZA LIKE ILLNESS (flu like symptoms), BODY TEMPERATURE FLUCTUATION (she turned hot then cold then hot again), VACCINATION SITE PRURITUS (arm started "itching beyond itching"), VACCINATION SITE INDURATION (injection site became a lump the size of her hand), HEADACHE (headaches) and FATIGUE (fatigued). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (arm was warm), PHOTOPHOBIA (light sensitivity), MALAISE (didn't feel great), INFLUENZA LIKE ILLNESS (flu like symptoms), BODY TEMPERATURE FLUCTUATION (she turned hot then cold then hot again), VACCINATION SITE PRURITUS (arm started "itching beyond itching"), VACCINATION SITE INDURATION (injection site became a lump the size of her hand), VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE ERYTHEMA (arm was red), HEADACHE (headaches) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Blood glucose fluctuation
Clinical narrative: her glucose of 189 dropped to 70; having difficulty keeping her blood sugars up and it is dropping quicker than normal; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (her glucose of 189 dropped to 70) and BLOOD GLUCOSE FLUCTUATION (having difficulty keeping her blood sugars up and it is dropping quicker than normal) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus (since 14 years).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced BLOOD GLUCOSE DECREASED (her glucose of 189 dropped to 70) and BLOOD GLUCOSE FLUCTUATION (having difficulty keeping her blood sugars up and it is dropping quicker than normal). At the time of the report, BLOOD GLUCOSE DECREASED (her glucose of 189 dropped to 70) and BLOOD GLUCOSE FLUCTUATION (having difficulty keeping her blood sugars up and it is dropping quicker than normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: swelling occurred to tear troughs; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling occurred to tear troughs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: RESTYLANE L on 14-Sep-2020.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE SWELLING (swelling occurred to tear troughs). At the time of the report, EYE SWELLING (swelling occurred to tear troughs) outcome was unknown.            As reported injected in tear troughs with Restylane-L on 14-Sep-2020. Swelling occurred to tear toughs 24 hours following second vaccine. Treatment information was not provided. Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant information was received on 29-Apr-2021 content additional reporter information.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in upper and lower extremities; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in upper and lower extremities) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness in upper and lower extremities). At the time of the report, HYPOAESTHESIA (Numbness in upper and lower extremities) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Limb discomfort, Pain
Clinical narrative: Sore shot arm; Tired and achy; Tired and achy; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Sore shot arm), PAIN (Tired and achy), DIARRHOEA (Diarrhea) and FATIGUE (Tired and achy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Diverticulitis (Severe diverticulitis and had three one feet sections of his intestines removed and wore an ostomy bag for one and one-half years) in 2014, Heart attack (and got two stents in his arteries in the heart) in 2015 and Hartmann's pouch procedure (was reversed in 2016) in 2014. Concurrent medical conditions included Type 2 diabetes mellitus and Gastric disorder (has a sensitive stomach and gets diarrhea from eating too much beef, fish, dairy products, etc.).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIMB DISCOMFORT (Sore shot arm), PAIN (Tired and achy), DIARRHOEA (Diarrhea) and FATIGUE (Tired and achy). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (Sore shot arm), PAIN (Tired and achy) and FATIGUE (Tired and achy) outcome was unknown and DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.  It was reported that the diarrhea has been yellow and smelly and severe.   This case was linked to MOD-2021-028292 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: Additional Information received. Patient's medical history and event information updated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Very achy; Stiff Muscle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Very achy) and MUSCULOSKELETAL STIFFNESS (Stiff Muscle) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis, Penicillin allergy and Soy allergy.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Very achy) and MUSCULOSKELETAL STIFFNESS (Stiff Muscle). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (Very achy) and MUSCULOSKELETAL STIFFNESS (Stiff Muscle) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: significant follow up received on 16 JUL 2021, Patient Demographics, Vaccine information and event updated.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: feeling unwell; fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling unwell) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling unwell) and PYREXIA (fever). At the time of the report, MALAISE (feeling unwell) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment products were not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 31-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Induced abortion. Concurrent medical conditions included Asthma. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 25-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 13-Sep-2020 and the estimated date of delivery was 13-Jun-2021. On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-third week of the pregnancy.  On 25-Feb-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Oct-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The date of positive pregnancy test was 05-Oct2020 and ultrasound was done on 25-Jan-2021. The patient has an established prenatal care. Treatment medications were not reported.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Body temperature, Body temperature increased, Chills
Clinical narrative: joint pain; increased saliva production; chills; temperature was 98.4; eyes were tearing; shaking; pain at the injection site; headache; nausea; abdominal pain; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking) and ARTHRALGIA (joint pain) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea) and BODY TEMPERATURE INCREASED (temperature was 98.4). On an unknown date, the patient experienced SALIVARY HYPERSECRETION (increased saliva production), ARTHRALGIA (joint pain) and CHILLS (chills). On 04-Mar-2021, ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), ARTHRALGIA (joint pain), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and BODY TEMPERATURE INCREASED (temperature was 98.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 98.4 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Lacrimation increased, Nausea, Salivary hypersecretion
Clinical narrative: joint pain; increased saliva production; chills; temperature was 98.4; eyes were tearing; shaking; pain at the injection site; headache; nausea; abdominal pain; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking) and ARTHRALGIA (joint pain) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea) and BODY TEMPERATURE INCREASED (temperature was 98.4). On an unknown date, the patient experienced SALIVARY HYPERSECRETION (increased saliva production), ARTHRALGIA (joint pain) and CHILLS (chills). On 04-Mar-2021, ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), ARTHRALGIA (joint pain), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and BODY TEMPERATURE INCREASED (temperature was 98.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 98.4 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: joint pain; increased saliva production; chills; temperature was 98.4; eyes were tearing; shaking; pain at the injection site; headache; nausea; abdominal pain; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking) and ARTHRALGIA (joint pain) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea) and BODY TEMPERATURE INCREASED (temperature was 98.4). On an unknown date, the patient experienced SALIVARY HYPERSECRETION (increased saliva production), ARTHRALGIA (joint pain) and CHILLS (chills). On 04-Mar-2021, ABDOMINAL PAIN (abdominal pain), SALIVARY HYPERSECRETION (increased saliva production), LACRIMATION INCREASED (eyes were tearing), TREMOR (shaking), ARTHRALGIA (joint pain), INJECTION SITE PAIN (pain at the injection site), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and BODY TEMPERATURE INCREASED (temperature was 98.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 98.4 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Body temperature, Decreased appetite, Influenza like illness, Insomnia
Clinical narrative: Feeling a little sluggish; fever; Very nauseous; Loss of balance; overall pain; Could not sleep; No appetite; Full blown flu symptoms all night; Injection site pain; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance) and SLUGGISHNESS (Feeling a little sluggish) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain) and MYALGIA (muscle aches). On 25-Feb-2021, the patient experienced BALANCE DISORDER (Loss of balance), PYREXIA (fever) and NAUSEA (Very nauseous). On 26-Feb-2021, the patient experienced SLUGGISHNESS (Feeling a little sluggish). At the time of the report, PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance), SLUGGISHNESS (Feeling a little sluggish), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain), MYALGIA (muscle aches), PYREXIA (fever) and NAUSEA (Very nauseous) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) high.         Concomitant medications were not reported. Treatment information was not reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia, Sluggishness
Clinical narrative: Feeling a little sluggish; fever; Very nauseous; Loss of balance; overall pain; Could not sleep; No appetite; Full blown flu symptoms all night; Injection site pain; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance) and SLUGGISHNESS (Feeling a little sluggish) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain) and MYALGIA (muscle aches). On 25-Feb-2021, the patient experienced BALANCE DISORDER (Loss of balance), PYREXIA (fever) and NAUSEA (Very nauseous). On 26-Feb-2021, the patient experienced SLUGGISHNESS (Feeling a little sluggish). At the time of the report, PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance), SLUGGISHNESS (Feeling a little sluggish), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain), MYALGIA (muscle aches), PYREXIA (fever) and NAUSEA (Very nauseous) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) high.         Concomitant medications were not reported. Treatment information was not reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Feeling a little sluggish; fever; Very nauseous; Loss of balance; overall pain; Could not sleep; No appetite; Full blown flu symptoms all night; Injection site pain; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance) and SLUGGISHNESS (Feeling a little sluggish) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain) and MYALGIA (muscle aches). On 25-Feb-2021, the patient experienced BALANCE DISORDER (Loss of balance), PYREXIA (fever) and NAUSEA (Very nauseous). On 26-Feb-2021, the patient experienced SLUGGISHNESS (Feeling a little sluggish). At the time of the report, PAIN (overall pain), INSOMNIA (Could not sleep), DECREASED APPETITE (No appetite), BALANCE DISORDER (Loss of balance), SLUGGISHNESS (Feeling a little sluggish), INFLUENZA LIKE ILLNESS (Full blown flu symptoms all night), VACCINATION SITE PAIN (Injection site pain), MYALGIA (muscle aches), PYREXIA (fever) and NAUSEA (Very nauseous) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) high.         Concomitant medications were not reported. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site rash, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Covid arm; arm was a little sore; arm is swollen; arm is red; arm is itchy; A spontaneous  report was received from a consumer  regarding  a female patient who had Injection site rash , Peripheral swelling , Erythema , Pruritus , Pain in extremity .  The patient's medical history is not mentioned .   Concomitant product use was not provided .  The patient received their 1st dose of mRNA-1273 on  (date unknown ) , unknown batch number and  2 nd dose  was taken on  25/Feb/2021 batch no unknown  for prophylaxis of COVID-19 infection.  Caller states she is reporting having Covid arm, her arm is swollen, red, and itchy. It seems to be going away but still itchy.  She received her first dose and her arm was a little sore.   These effects are with her second shot she received on 25feb2021 and symptoms started on 26feb2021.  Treatment given was unknown .  He gave her consent for follow up .  Lab parameters were not provided .   No other reactions reported.   Action taken with mRNA-1273 in response to the event was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Pain
Clinical narrative: It's painful and it goes up into my shoulder; Rash at the injection site; Rash is so itchy; Its painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (It's painful and it goes up into my shoulder), INJECTION SITE RASH (Rash at the injection site), INJECTION SITE PRURITUS (Rash is so itchy) and INJECTION SITE PAIN (Its painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN (It's painful and it goes up into my shoulder), INJECTION SITE RASH (Rash at the injection site), INJECTION SITE PRURITUS (Rash is so itchy) and INJECTION SITE PAIN (Its painful). At the time of the report, PAIN (It's painful and it goes up into my shoulder), INJECTION SITE RASH (Rash at the injection site), INJECTION SITE PRURITUS (Rash is so itchy) and INJECTION SITE PAIN (Its painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: Had trouble sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Had trouble sleeping) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, PROPRANOLOL, ENALAPRIL MALEATE (LOTRIL [ENALAPRIL MALEATE]), TIZANIDINE and TEMAZEPAM for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Had trouble sleeping). At the time of the report, INSOMNIA (Had trouble sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Severe explosive diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe explosive diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included TOFACITINIB CITRATE (XELJANZ XR) for Rheumatoid arthritis.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (Severe explosive diarrhea). At the time of the report, DIARRHOEA (Severe explosive diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment of events was reported.  The reporter mentioned the patient withheld her doses of Xeljanz for 5 days prior to her second dose of Moderna vaccine and did not experience the event of explosive diarrhea again.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up received: Medical history, vaccine information, concomitant medication information and event information were updated.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site warmth, Swelling
Clinical narrative: Redness spreads like it was a mess like 6; Hot to touch; Redness around the injection site; Painful like when you get a shot; little swelling; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness spreads like it was a mess like 6), SWELLING (little swelling), INJECTION SITE WARMTH (Hot to touch), INJECTION SITE ERYTHEMA (Redness around the injection site) and INJECTION SITE PAIN (Painful like when you get a shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced SWELLING (little swelling). On 26-Feb-2021, the patient experienced ERYTHEMA (Redness spreads like it was a mess like 6), INJECTION SITE WARMTH (Hot to touch), INJECTION SITE ERYTHEMA (Redness around the injection site) and INJECTION SITE PAIN (Painful like when you get a shot). At the time of the report, ERYTHEMA (Redness spreads like it was a mess like 6), SWELLING (little swelling), INJECTION SITE WARMTH (Hot to touch), INJECTION SITE ERYTHEMA (Redness around the injection site) and INJECTION SITE PAIN (Painful like when you get a shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Hyperhidrosis, Nasopharyngitis, Rhinorrhoea
Clinical narrative: Runny nose; Coughing; Sweating; Cold; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), COUGH (Coughing), HYPERHIDROSIS (Sweating) and NASOPHARYNGITIS (Cold) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included CARVEDILOL for an unknown indication.    On 24-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced RHINORRHOEA (Runny nose), COUGH (Coughing), HYPERHIDROSIS (Sweating) and NASOPHARYNGITIS (Cold). At the time of the report, RHINORRHOEA (Runny nose), COUGH (Coughing), HYPERHIDROSIS (Sweating) and NASOPHARYNGITIS (Cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil count increased, Granulocyte count decreased
Clinical narrative: Eosinophil count was high; granulocyte is low; This spontaneous case was reported by a consumer and describes the occurrence of EOSINOPHIL COUNT INCREASED (Eosinophil count was high) and GRANULOCYTE COUNT DECREASED (granulocyte is low) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced EOSINOPHIL COUNT INCREASED (Eosinophil count was high) and GRANULOCYTE COUNT DECREASED (granulocyte is low). At the time of the report, EOSINOPHIL COUNT INCREASED (Eosinophil count was high) and GRANULOCYTE COUNT DECREASED (granulocyte is low) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hardness Near the Injection Site; Itchy Sensation - Near Injection Site; Hot to Touch - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE INDURATION (Hardness Near the Injection Site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Claritin. Concomitant products included Allergy Shot                                                   Allergies and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site). On an unknown date, the patient experienced VACCINATION SITE INDURATION (Hardness Near the Injection Site). At the time of the report, VACCINATION SITE WARMTH (Hot to Touch - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue
Clinical narrative: some of the dose dripped down the patients arm; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DEVICE CONNECTION ISSUE (some of the dose dripped down the patients arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 24-Jan-2021, the patient experienced DEVICE CONNECTION ISSUE (some of the dose dripped down the patients arm). At the time of the report, DEVICE CONNECTION ISSUE (some of the dose dripped down the patients arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Side effects show up 10 to 14 days after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE REACTION (Side effects show up 10 to 14 days after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Side effects show up 10 to 14 days after vaccination). At the time of the report, VACCINATION SITE REACTION (Side effects show up 10 to 14 days after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lymphadenopathy, Rash
Clinical narrative: skin rash; Swollen lymph nodes behind neck, ear and jaw; facial rash; facial redness; A spontaneous report was received from a Healthcare Professional concerning a 73-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events skin rash, swollen lymph nodes behind neck, swollen lymph nodes behind ear, swollen lymph nodes behind jaw, facial redness, facial rash.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029k20A) intramuscularly for prophylaxis of COVID-19 infection.  The patient experienced skin rash. On 29 Jan 2021, the patient experienced the events swollen lymph nodes behind neck.,swollen lymph nodes behind ear, swollen lymph nodes behind jaw. On 22 Jan 2021, the patient experienced the events facial redness. facial rash.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The Outcome of the event was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm subsequently hurt; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (Arm subsequently hurt) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 30-Jan-2020, the patient experienced PAIN IN EXTREMITY (Arm subsequently hurt). At the time of the report, PAIN IN EXTREMITY (Arm subsequently hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PYREXIA (Fever of 101). At the time of the report, PYREXIA (Fever of 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 101 degree (plane angle).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Severe headache; Chills; Fatigue; Fever; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm pain). At the time of the report, HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Fatigue, Nausea, Obstruction
Clinical narrative: tested positive COVID19 after vaccination; diarrhea; congestion; nausea; tiredness; A spontaneous report was received from a Healthcare Professional concerning a patient aged between 30-50 years who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced covid19, nausea, diarhoea , fatigue and congestion .  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number not provided ) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date patient experienced covid19, nausea, diarrhea , fatigue and congestion.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of covid19, nausea, diarrhea , fatigue and congestion was not reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Myalgia, Pyrexia, Rhinorrhoea
Clinical narrative: runny nose; achy; cough; fever; tired over the weekend; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), COUGH (cough), MYALGIA (achy), FATIGUE (tired over the weekend) and PYREXIA (fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021 at 12:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (tired over the weekend). On 08-Feb-2021, the patient experienced COUGH (cough) and PYREXIA (fever). On 09-Feb-2021, the patient experienced RHINORRHOEA (runny nose) and MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) on 09-Feb-2021 for Pain and Fever, at an unspecified dose and frequency. On 07-Feb-2021, FATIGUE (tired over the weekend) had resolved. On 12-Feb-2021, COUGH (cough) and PYREXIA (fever) had resolved. At the time of the report, RHINORRHOEA (runny nose) and MYALGIA (achy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative, after first dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported concomitant medications as none but she usually took Vitamin D.   This case was linked to MOD-2021-068364, MOD-2021-068364.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up received: Updated patient demographics and cough event outcome to recovered/resolved. Added new event fever and lab data.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: runny nose; achy; cough; fever; tired over the weekend; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), COUGH (cough), MYALGIA (achy), FATIGUE (tired over the weekend) and PYREXIA (fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021 at 12:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (tired over the weekend). On 08-Feb-2021, the patient experienced COUGH (cough) and PYREXIA (fever). On 09-Feb-2021, the patient experienced RHINORRHOEA (runny nose) and MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) on 09-Feb-2021 for Pain and Fever, at an unspecified dose and frequency. On 07-Feb-2021, FATIGUE (tired over the weekend) had resolved. On 12-Feb-2021, COUGH (cough) and PYREXIA (fever) had resolved. At the time of the report, RHINORRHOEA (runny nose) and MYALGIA (achy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative, after first dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported concomitant medications as none but she usually took Vitamin D.   This case was linked to MOD-2021-068364, MOD-2021-068364.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up received: Updated patient demographics and cough event outcome to recovered/resolved. Added new event fever and lab data.